Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

130.03
+1.140.89%
Volume:22.44K
Turnover:2.92M
Market Cap:533.12M
PE:6.74
High:130.65
Open:129.17
Low:129.16
Close:128.89
52wk High:131.68
52wk Low:90.01
Shares:4.10M
Float Shares:4.10M
Volume Ratio:1.37
T/O Rate:0.55%
Dividend:1.06
Dividend Rate:0.82%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.60
PE(LYR):5.98

Loading ...

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
38 mins ago

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Reuters
·
2 hours ago

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS
·
10 hours ago

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Reuters
·
10 hours ago

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
10 hours ago

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
10 hours ago

Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet

TIPRANKS
·
Aug 22

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Aug 22

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Johnson & Johnson Names New Vice President for Litigation

Reuters
·
Aug 22

Stocks Ex-Dividend August 25

Dow Jones
·
Aug 22

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

TIPRANKS
·
Aug 22

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now

TIPRANKS
·
Aug 22